Sitagliptin phosphate ine(Oxedrine) 100 mg/kg Moxifloxacin in mice

100 mg/kg Moxifloxacin in mice gives activity comparable to INH

Formula: C20H29N2NaO11S

NVP-ACC789 which is given in daily oral doses for 6 days blocks VEGF-induced angiogenesis in a dose-dependent manner

Sofosbuvir 13CD3 (PSI-7977 13CD3) is the deuterium labeled Sofosbuvir

GBT440 increases haemoglobin oxygen affinity

Sitagliptin phosphate ine(Oxedrine) 100 mg/kg Moxifloxacin in miceSitagliptin (INN; previously identified as MK 0431 and sold under the trade name Januvia) is an oral antihyperglycemic (anti diabetic drug) of the dipeptidyl peptidase 4 (DPP 4) inhibitor class. It was developed and is marketed by Merck & Co. This enzyme inhibiting drug is used either alone or in combination with other oral antihyperglycemic agents (such as metformin or a thiazolidinedione) for treatment of diabetes mellitus type 2. The benefit of